Browsing: cancer

Researchers at Helmholtz Munich, the Heidelberg Faculty of Medicine at Heidelberg University, the German Center for Diabetes Research (DZD) and…

A new form of proton therapy-designed to deliver cancer-killing radiation therapy in less than a second, through fewer total sessions,…

BeOne Medicines, Ltd., a global oncology company, today announced a voluntary agreement with the U.S. Government to expand access to…

One of Australia’s largest real world studies of younger adults with advanced bowel cancer has identified important differences between cancers…

Revolution Medicines set a sticker price of about $480,000 a year, or $663 a tablet, for its new pancreatic cancer…

Many breast cancer survivors whose treatment caused them to develop problems with their heart function can safely stop their medication after their heart recovers and most won’t need to continue treatment long-term, according to a study…

The U.S. Food and Drug Administration (FDA) has approved daraxonrasib for patients whose pancreatic cancer has spread to other parts…

Australian researchers are challenging decades-old assumptions about brain cancer treatment in a bid to make radiation therapy more effective against…

The U.S. Food and Drug Administration (FDA) has approved daraxonrasib, an oral multi-selective RAS(ON) inhibitor, for adults with metastatic pancreatic…

Australian researchers are challenging decades-old assumptions about brain cancer treatment in a bid to make radiation therapy more effective against…